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Under inflammatory conditions, inflammatory cells release reactive oxygen species (ROS)
and reactive nitrogen species (RNS) which cause DNA damage. If not appropriately
repaired, DNA damage leads to gene mutations and genomic instability. DNA damage
checkpoint factors (DDCF) and DNA damage repair factors (DDRF) play a vital role in
maintaining genomic integrity. However, how DDCFs and DDRFs are modulated under
physiological and pathological conditions are not fully known. We took an experimental
database analysis to determine the expression of 26 DNA DDCFs and 42 DNA DDRFs in
21 human and 20 mouse tissues in physiological/pathological conditions. We made the
following significant findings: (1) Few DDCFs and DDRFs are ubiquitously expressed in
tissues while many are differentially regulated.; (2) the expression of DDCFs and DDRFs
aremodulated not only in cancers but also in sterile inflammatory disorders andmetabolic
diseases; (3) tissue methylation status, pro-inflammatory cytokines, hypoxia regulating
factors and tissue angiogenic potential can determine the expression of DDCFs and
DDRFs; (4) intracellular organelles can transmit the stress signals to the nucleus, which
may modulate the cell death by regulating the DDCF and DDRF expression. Our results
shows that sterile inflammatory disorders and cancers increase genomic instability,
therefore can be classified as pathologies with a high genomic risk. We also propose
a new concept that as parts of cellular sensor cross-talking network, DNA checkpoint
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and repair factors serve as nuclear sensors for intracellular organelle stresses. Further,
this work would lead to identification of novel therapeutic targets and new biomarkers
for diagnosis and prognosis of metabolic diseases, inflammation, tissue damage and
cancers.
Keywords: DNA damage checkpoint and repair factors, inflammation, cancers, genomic instability, danger
associated molecular patterns (DAMPs)
INTRODUCTION
Chronic inflammation is induced by damage associated
molecular patterns (DAMPs) derived from endogenous
metabolites. Further, infectious agents-, and physiochemical
factors-derived pathogen-associated molecular patterns
(PAMPs) generated during tissue injury or microbial
invasion promote inflammation via responsive innate
immune system (Yang et al., 2008). Generally, chronic
inflammation contributes to approximately 25% of human
cancers (Kawanishi et al., 2017). Epidemiologic studies
implicated that the risk for development of cancer is increased
in patients with inflammatory cardiovascular disease (van
Kruijsdijk et al., 2013; Alameddine et al., 2017; Hasin et al.,
2017).
Under inflammatory conditions, inflammatory cells release
reactive oxygen species (ROS) and reactive nitrogen species
(RNS) which cause DNA damage. If not appropriately repaired,
DNA damage leads to gene mutations and genomic instability.
One of the early events in the DNA damage response (DDR) is
the recruitment of poly (ADP-ribose) polymerase 1 (PARP1).
In addition, DNA damage checkpoint factors (DDCFs)
play a crucial role by arresting the cell cycle to allow the
time to repair once a damage to DNA has taken place. The
detailed characterization of DDCFs has classified as many
as 26 human proteins into four categories including DNA
damage sensors, mediators, transducers and effectors (Blanpain
et al., 2011). Additionally, DNA damage repair machinery
is composed of 42 DNA damage repair factors (DDRFs).
DDRFs are grouped into eight subgroups based on their
DNA repairing mechanisms such as base excision repair,
nucleotide excision repair, homologous recombination repair,
non-homologous end joining, microhomology-mediated
end-joining, mismatch repair, and shared mechanism
subgroups (Blanpain et al., 2011; Iyama and Wilson, 2013).
However, how chronic inflammatory disorders such as
metabolic cardiovascular diseases and cancers modulate
the expression of these DDCFs and DDRFs remains poorly
defined.
In spite of recent significant progress in this front, there
are a few aspects of DDCFs and DDRFs that are not explored.
The questions regarding how DDCFs and DDRFs expressed in
tissue and whether altered homeostasis modulate the expression
pattern are not known (Lu et al., 2004, 2017). Furthermore,
whether the expression of DDCFs and DDRFs is modulated
in sterile inflammatory disorders and metabolic diseases is
not clear (Archacki and Wang, 2004). Most of the chronic
inflammatory disorders induce the production of ROS and
intracellular organelle stresses. Organelle stresses such as ER
(endoplasmic reticulum) stress, and mitochondrial stress induce
cell death signaling pathways (Rathore et al., 2015). We recently
found that caspase-1/inflammasome pathway plays a significant
role in sensing metabolic danger signal associated molecular
patterns (DAMPs) in hyperlipidemia (Yin et al., 2009, 2015;
Shen et al., 2010; Lopez-Pastrana et al., 2015; Li Y. F. et al.,
2016, 2017; Wang L. et al., 2016), hyperhomocysteinemia (Xi
et al., 2016) and chronic kidney disease (Ferrer et al., 2016)
and initiate inflammation/inflammatory cell death (pyroptosis).
We also found that pro-atherogenic endogenous metabolites
lysophospholipids such as lysophosphatidylcholines (lysoPC)
act as conditional DAMPs. We previously proposed that
lysoPC bind to their intrinsic receptors (conditional DAMP
receptors) (Wang X. et al., 2016; Shao et al., 2017; Sun
et al., 2018), and induce mitochondrial reactive oxygen species
(mitoROS) (Li et al., 2013, 2016, 2017a; Cheng et al., 2017) to
upregulate aortic endothelial cell activation genes via histone
3 lysine 14 acetylation-AP1-dependent pathway (Li et al.,
2018). However, it is not clear whether DDCFs and DDRFs
act as the nuclear sensor for intracellular organelle stress,
a part of our newly proposed cellular sensor cross-talking
network. We postulated that the expression of DDCFs and
DDRFs is modulated in response to intracellular organelle
stresses and ultimately determine the genomic stability and cell
death.
To address these questions, we took a “panoramic view”
at the tissue expression patterns of 26 DDCFs and 42
DDRFs. Our results demonstrated that (1) 15 out of 21
human tissues express most of DDCFs and 14 human
tissues express most of DDRFs; (2) four DDCFs such as
PARP1, XRCC6, XRCC5, PRKDC, and six DDRFs including
APEX1, XPC, ERCC3, ERCC5, HMGB1, and MLH1 are
ubiquitously expressed. We also found that selective DDCFs
and DDRFs are upregulated in cells from patients with
coronary artery disease, rheumatoid arthritis, Hutchinson
syndrome and various cancers. Furthermore, our analysis
showed that intracellular organelle stresses can modulate
the gene expression of DDCFs and DDRFs. Therefore, our
findings suggest that via signaling pathways that are yet to
be determined, intracellular organelle stresses are conveyed
to the nucleus; and in response to these stresses, DDCFs,
and DDRFs may play a significant role in determining the
cell fate. Our findings provide novel insights on DDCFs and
DDRFs as new therapeutic targets in metabolic diseases and
inflammations.
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MATERIALS AND METHODS
Tissue Expression Profiles of DDCF and
DDRF Genes
An experimental data mining strategy (Figure 1) was used to
analyze the expression profiles of mRNA transcripts of 26 DDCF
and 42 DDRF genes in 21 different human and 20 mouse tissues
including heart and vasculature as we previously described (Xu
et al., 2018).
Expression Profiles of DDCFs and DDRFs
in Disease Models and Cell Activity
Microarray datasets were collected from the Array Express
of European Bioinformatics Institute, which stores data from
high-throughput functional genomics experiments. These data
include the information of the expression of DDCFs and DDRFs
through experiments submitted directly to Array Express or
imported from the NCBI Gene Expression Omnibus database
(Figure 1). The numbers of GEO datasets that were used
are as follows: GSE55235, GSE81622, GSE57376, GSE27335,
GSE16879, GSE27411, GSE41751, GSE1297, GSE32614,
GSE13205, GSE3253, GSE34378, GSE77955, GSE79973,
GSE62452, GSE45670, GSE45001, GSE70951, GSE46602,
GSE36668, GSE3218, GSE75037, GSE71963, GSE9327,
GSE49598, GSE11322, GSE75150, GSE39621, GSE56102,
GSE67227, GSE40207, GSE60413, GSE67676, GSE13512,
GSE57691, GSE9874, GSE23561, GSE19339, GSE30528,
GSE25724, GSE23561, GSE55100, GSE6088, GSE43760,
FIGURE 1 | Flow chart of database mining strategy and two parts of data organization. (I) Database mining strategy was used to generate tissue expression profiles
of genes in physiological condition. DDCFs, DNA damage checkpoint factors; DDRFs, DNA damage repair factors; NCBI, National Center of Biotechnology
Information; IDs, gene identifications; EST, Expressed sequence tag; VEGF, Vascular endothelial growth factor; SAM, S-adenosylmethionine;
SAH:S-adenosylhomocysteine. (II) DNA damage checkpoint and repair factors expression changes were analyzed with experimental data from the microarray
datasets in diseases, after treated with LPS, MRP8, some inflammatory cytokines, and after oxidative stress, organelle autoregulation associated gene knockout.
*NIH-Geo website: www.ncbi.nlm.nih.gov/geo/; GEO2R website: www.ncbi.nlm.nih.gov/geo/geo2r/.
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GSE60436, GSE46262, GSE15575, GSE9490, GSE13139,
GSE36287, GSE68942, GSE56681, GSE6257, GSE37624,
GSE39629, GSE8969, GSE35124, GSE6623, GSE8726, GSE92530,
GSE52550. The dataset numbers that were used for each analysis
is shown in tables.
Tissue SAH and SAM Measurements in
Mice
The concentration of S-adenosyl methionine (SAM) and S-
adenosyl homocysteine (SAH) were measured in six tissues
(heart, liver, lung, kidney, spleen, and brain) as we described
elsewhere (Wang et al., 2017).
RESULTS
Most of the DNA Damage Checkpoint
Factors and DNA Damage Repair Factors
Are Differentially Expressed in Human and
Mouse Tissues
DDCF Expression Profile in Human Tissues
Twenty-six DDCFs have been characterized and classified in to
three subgroups named DNA damage sensors, DNA damage
mediators and transducers (Blanpain et al., 2011). However,
whether the different stimulatory/suppressive environments
and different types and numbers of cells present in a tissue
determine the expression levels of three DDCF subgroups is
not known. Therefore, we hypothesized that the differences
in stimulatory/suppressive environments in tissues may
differentially modulate the expression of DDCFs in human
tissues.
To examine this hypothesis we conducted an extensive
literature survey on most recently published articles. We selected
16 DNA damage sensors, 5 DNA damage mediators and 5 DNA
damage transducers (Supplementary Table 1 and Figure 2) for
our analysis. We then examined the expression patterns of all the
26 DDCFs in 21 human tissues by searching DNA sequencing-
based data of mRNA levels at physiological conditions. Based on
the level of DDCFs expression amongst human tissues examined,
we classified the tissues into following three groups: if the
expression of the gene is higher than the threshold, the gene was
categorized in to highly expressed (++) group, if below, then the
gene was considered to be low expressed gene (+). The genes that
are not expressed is shown as () (Supplementary Table 2). The
method of calculation the threshold is shown in Supplemental
Figure 1 and was explained previously (Wang X. et al., 2016;
Wang et al., 2017; Xu et al., 2018).
Out of the 26 DDCFs analyzed, four factors including three
DNA damage sensor factors PARP1 (sensor), XRCC6 (sensor),
XRCC5 (sensor) and one DNA damage transducer PRKDC
are ubiquitously expressed in 21 human tissues in normal
physiological conditions. This emphasize that these 4 genes have
important house-keeping functions in sensing and monitoring
DNA damage in tissues. The rest of the DDCFs are differentially
expressed in human tissues. Interestingly, testis and intestine
expressed all the DDCFs that we analyzed in this study. The
adipose tissue expressed the least number of DDCFs. In contrast
to the rest of the tissues, muscles, lymph nodes and testis had
the most DDCF categorized in to highly expressed (++) group
(73.1, 23.1, and 19.2% respectively). Therefore, it can be suggested
that these tissues may require larger contribution from cell cycle
checkpoints and house-keeping checkpoints to maintain genome
integrity.
DDCF Expression Profile in Mouse Tissues
In addition, we also examined the mouse homologs of DDCFs
(Supplementary Table 3). Unlike for human tissues, we could not
identify any DDCFs that are ubiquitously expressed. However,
Parp1 and Rpa1 were expressed in most of the mouse tissues
included in this study. Interestingly, we could identify only
Parp1 expressed in the adrenal gland. Bone marrow, brain,
embryonic tissue and pancreas expressed a larger variety of
DDCFs compared to the rest of the tissues analyzed. In contrast
to the human tissues, most of theDDCF fell in to highly expressed
(++) category in mouse tissue.
These results suggest the consistent expression of DDCFs in
most human and mouse tissues, implying their physiological
functions in sensing and guarding the cells against DNA
damages. Our results on high expression of DDCFs in muscle
are correlated well with the report demonstrating that long living
tissues, such as muscle, are composed of terminally differentiated
cells that irreversibly withdraw the cell cycle, and do not have the
opportunity to cyclically monitor the integrity of their genome,
by means of cell cycle checkpoints as dividing cells do (Latella
and Puri, 2015).
DDRF Expression in Human Tissues
Many pathological DNA breaks are induced by ionizing
radiation, reactive oxygen species, DNA replication errors,
inadvertent cleavage by nuclear enzymes, as well as physiological
(regulated) breaks occurring during V(D)J recombination and
immunoglobulin heavy chain class switch recombination, require
end processing by nucleases and DNA polymerases to repair the
DNA (Chang et al., 2017). Therefore, DDRFs play an important
role in maintaining genomic integrity in cells. Herein, we
hypothesized that similarly to DDCFs tissue expression profile,
DDRFs may adapt a tissue expression pattern with a few house-
keeping DDRFs and some inducible DDRFs.
To examine this hypothesis, we collected 42 DDRFs classified
into five subgroups as shown in Supplementary Table 4 and
Figure 3 (Iyama and Wilson, 2013). We then categorized the
42 DDRFs in to highly expressed (++), low expressed (+)
and not expressed () as we did for DDCFs (Supplementary
Table 5). We found that six DDRFs including APEX1 (BER
subgroup), XPC (NER), ERCC3 (NER), ERCC5 (NER), HMGB1
(MMR), and MLH1 (MMR) are ubiquitously expressed in all
of 21 human tissues examined in physiological conditions. This
emphasize that these 6 DDRFs have important house-keeping
functions in DNA damage repair in tissues. The rest of the
DDRFs are differentially expressed in human tissues. Similar to
the trend seen for DDCFs expression, muscles and testis (except
lymph node) had larger variety of DDRFs classified in to highly
expressed (++) group. Adipose tissue and the adrenal gland
recorded the least variety of DDRF expression.
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FIGURE 2 | DNA damage checkpoints and the components involved in their signal transduction pathways are classified in to conceptual categories named sensors,
mediators, transducers, and effectors. Consequently, DNA damage may lead to cell cycle arrest, senescence, and apoptosis. RAD17, RAD17 checkpoint clamp
loader component; RFC, Replication factor C; RAD9, chromatin-binding protein; RAD1, RAD1 checkpoint DNA exonuclease; HUS1, Hus1 checkpoint homolog; RPA,
replication protein A; ATRIP, ATR interacting protein; PARP1, Poly(rC)-binding protein 1; PARP2, Poly(rC)-binding protein 2; MRE11, meiotic recombination 11
homolog A; RAD50, RAD50 homolog; NBS1, Nibrin; Ku70, X-ray repair cross complementing 6 (XRCC6); Ku80, X-ray repair cross complementing 5 (XRCC5); 53BP,
P53 binding protein 1; MDC1, mediator of DNA damage checkpoint protein 1; H2AX, H2A histone family, member X; BRCA1, Breast cancer 1; TopBP1,
topoisomerase II binding protein 1; ATM, Ataxia telangiectasia mutated; ATR, Ataxia telangiectasia and Rad3 related; DNA-PK, DNA-activated, catalytic polypeptide;
CHEK1, checkpoint kinase 1; CHEK2, checkpoint kinase 2; CDC25A, cell division cycle 25A; CDC25C, cell division cycle 25C.
Construction of a Tissue Pyramid Model Based on
the Expression Level of DDCFs and DDRFs in Human
Tissues
Based on the number of DDCFs and DDRFs classified in to
highly expressed (++) group, we further categorized the tissues
in to three groups: high variety (tissues that had H%∗ > 19
in Supplementary Tables 2, 3, 5, 6), moderate variety (5% ≤
H%∗ ≤ 19% in Supplementary Tables 2, 3, 5, 6) and low variety
(H%∗ < 5% in Supplementary Tables 2, 3, 5, 6). We depicted
these tissue categories for DDCFs and DDRFs in a tissue pyramid
model as shown in Figure 4. Two separate tissue pyramid models
were constructed for mouse and human tissues. Interestingly,
muscle and testis is included in the first tier for both DDCFs and
DDRFs in human tissue pyramid. Furthermore, the tissues that
expressed most of DDCFs are correlated well with the tissues
expressed most of DDRFs, implying that they are functionally
connected inmaintaining genomic integrity in tissues. Compared
to human tissues, mice have higher numbers of tissues classified
in top tier and middle tier, which may result from the differences
of humans and mice in their living environments.
Human Vascular, Autoimmune, Digestive,
Aging Diseases Tend to Upregulate DDCFs
and DDRFs Than Downregulation,
Whereas Metabolic Diseases Show Equal
Modulation of DNA Damage Factors and
Repair Factors
It has been reported that DNA damages and DNA strand breaks
not only occur in physiological conditions but also happen in
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FIGURE 3 | Five DNA damage repair systems have been characterized including: (A) DR, Direct reversal; (B) NER, Nucleotide excision repair; (C) BER, Base excision
repair; (D) DSBR, Double strand break repair, and (E) MMR, mismatch repair. Of note, DSBR is divided into three major pathways: Homologous recombination repair,
nonhomologous end joining and microhomology mediated end-joining. Each of DNA change repair systems are triggered by specific DNA damage agents. Of note,
HMGB1 is involved in three pathways, NER, BER, and MMR. MGMT, O6-methylguanine-DNA methyltransferase; ALKBH2, AlkB, alkylation repair homolog 2;
ALKBH3, AlkB, alkylation repair homolog 3; XPC, Xeroderma pigmentosum, complementation group C; RAD23B, RAD23 homolog B; XPA, Xeroderma pigmentosum,
complementation group A; XPD, Excision repair cross-complementing rodent repair deficiency, complementation group 2; XPB, Excision repair cross-complementing
rodent repair deficiency, complementation group 3; ERCC1, Excision repair cross-complementing rodent repair deficiency, complementation group 1; XPG, Excision
repair cross-complementing rodent repair deficiency, complementation group 5; XPF, Excision repair cross-complementing rodent repair deficiency, complementation
group 4; LIG1, Ligase I, DNA, ATP-dependent; CSA, Excision repair cross-complementing rodent repair deficiency, complementation group 8; CSB, Excision repair
cross-complementing rodent repair deficiency, complementation group 6; HMGB1, High mobility group box 1; OGG1, 8-oxoguanine DNA glycosylase; NEIL1, Nei
endonuclease VIII-like 1; MUTYH, mutY homolog; UNG, Uracil-DNA glycosylase; SMUG1, Single-strand-selective monofunctional uracil-DNA glycosylase 1; MPG,
N-methylpurine-DNA glycosylase; APEX1, APEX nuclease (multifunctional DNA repair enzyme) 1; APEX2, APEX nuclease (apurinic/apyrimidinic endonuclease) 2;
POLβ, Polymerase (DNA directed), beta; PNKP, Polynucleotide kinase 3
′
-phosphatase; XRCC2, X-ray repair complementing defective repair in Chinese hamster cells
2; XRCC3, X-ray repair complementing defective repair in Chinese hamster cells 3; BRCA2, Breast cancer 2; RAD52, RAD52 homolog; RAD51, RAD51 homolog;
LIG4, Ligase IV, DNA, ATP-dependent; XLF, Nonhomologous end-joining factor 1; XRCC4, X-ray repair complementing defective repair in Chinese hamster cells 4;
XRCC1, X-ray repair complementing defective repair in Chinese hamster cells 1; LIG3, Ligase III, DNA, ATP-dependent; MLH1, MutL homolog 1; MLH3, MutL
homolog 3; MSH2, MutS homolog 2; MSH3, MutS homolog 3; MSH6, MutS homolog 6; PMS1, Postmeiotic segregation increased 1; PMS2, Postmeiotic segregation
increased 2.
pathological conditions such as carcinogenesis/tumorigenesis
(Chang et al., 2017) as well as in chronic inflammation
(Kawanishi et al., 2017; Spanou et al., 2017). We hypothesized
that various disease conditions, including cardiovascular
diseases, autoimmune diseases, digestive diseases, aging diseases,
metabolic diseases and cancers affect genomic integrity by
modulating the expression of DDCFs and DDRFs. To examine
this hypothesis, we performed extensive database mining and
screening in the NIH-NCBI GEO DataSets database1 with the
microarray experiments from various disease settings including
vascular, autoimmune, digestive, aging, cancers/tumors from five
systems, and metabolic diseases.
We included 4 vascular diseases in to our study: aortic
occlusive disease, atherosclerosis, coronary artery disease and
1NIH-NCBI GEO DataSets database.
acute coronary syndrome and analyzed the expression changes
of DDCFs and DDRFs compared to healthy controls (Figure 5,
Supplementary Tables 7, 8). The results showed that in the
presence of vascular diseases, the tendency to upregulate the
expression of DDCFs and DDRFs in blood cells increase.
Furthermore, most of DDCFs and DDRFs tend to be upregulated
in the blood cells in coronary artery disease (Figure 5B). In
contrast, most of the downregulation of DDCFs and DDRFs
expression in the blood cells was observed in acute coronary
syndrome. The results showed that most of the vascular
disease have the tendency to upregulate DDCFs and DDRFs.
Furthermore, Venn analysis results showed that significantly
changed DDCFs and DDRFs among four vascular diseases are
mostly tissue-specific.
Interestingly, we saw a similar tendency in different
autoimmune disorders we analyzed in this study. Our study
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FIGURE 4 | Newly proposed “DNA damage checkpoint and repair factors” model in humans and mice. This tissue pyramid model suggests that DNA damage
response factors are differentially regulated in tissues. Further, abundance of DDCFs co-relate with the level of expression of DDRFs. H(%)* = number of genes with
high expression in each tissue/ number of DDCFS or DDRFS.
included 5 autoimmune disorders such as rheumatoid
arthritirs, osteoarthritis, systemic lupus erythematosus,
lesional skin and asthma. Out of the 26 DDCFs analyzed,
seven DDCFs were upregulated and we could not observe
attenuation of any of the DDCFs. We saw an increase
in expression of 3 DDRFs including Rad51 (Rheumatoid
arthritis), XRCC4 (lesional skin), and BRCA2 (asthma) while
1DDRFs was downregulated (Supplementary Tables 9, 10).
Similar to autoimmune disorders, the digestive disorders
that we included in this study showed an upregulation of
5 DDCFs while we did not observe any downregulation of
DDCFs. We studied 5 different digestive pathologies and
CHEK1 was upregulated in four digestive disorders. Further,
DDRFs also showed the tendency of being upregulated
than being downregulated. DDRF RAD52 was only
downregulated in ulcerative colitis (Supplementary Tables
11, 12).
Furthermore, we analyzed whether DDCFs and DDRFs
were modulated in metabolic disorders. For this analysis, we
extracted microarray datasets that were conducted on Type
2 diabetes, familial hypercholesterolemia, diabetic retinopathy
and also on cells that were treated with hyperglycemic and
pro-atherogenic stimuli (Supplementary Tables 13, 14). The
summary of our findings is shown in Figure 6. In type 2
diabetes, seven DDCFs and DDRFs were downregulated while
2 factors were upregulated in peripheral blood (Figure 6A).
This indicates that the modulation of DDCFs and DDRFs
by type 2 diabetes may be tissue specific. In addition, the
Venn analysis revealed that modulation of DDCFs and DDRFs
are disease specific (Figure 6B). However, the expression
changes of DDCFs and DDRFs may be attributed to disease
type; and tissue-specific responses to metabolic changes were
noticed.
Moreover, we studied the effect of aging and aging
disease (progeria) on the expression of DDCFs and DDRFs
(Supplementary Tables 15, 16). According to our findings, most
of the DDCFs and DDRFs that are modulated are prone to be
upregulated than being downregulated.
Taken together, our results demonstrated that DDCFs and
DDRFs tend to be upregulated than being downregulated in
various vascular pathologies, autoimmune disorders, digestive
disorders and aging diseases. In contrast, modulation of DDCFs
in metabolic diseases did not reveal a distinct pattern (7
upregulated and 6 downregulated among 13 DDCFs that are
modulated). Similarly, a distinct pattern could not be observed
in modulation of DDRFs in metabolic disorders.
Various Human Cancers Upregulate the
Expression of DNA Damage Checkpoint
Factors, and Repairing Factors, With
Exceptions Such as no Changes in
Pancreatic and Prostate Cancers and
Downregulation in Male Germ Cell Tumors
It has been reported that DNA damages and DNA strand breaks
often happen in carcinogenesis/tumorigenesis (Chang et al.,
2017). We hypothesized that various cancers/tumors modulate
the expression of DDCFs and DDRFs in differentially. To
examine this hypothesis, we examined 12 malignancies from
five systems including five digestive cancers, four reproductive
cancers, one respiratory cancer, one urinary cancer and one
lymphoma from hematopoietic system. As summarized in
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FIGURE 5 | Venn Diagram shows that significantly changed DNA damage checkpoint and repair factor in tissues among 4 different human vascular diseases are
mostly disease-specific. (A) DNA damage response factors has the tendency to be more upregulated that downregulated in 4 human vascular diseases included in
this study. (B) Venn diagram shows that the DNA damage checkpoint and factors that are upregulated during vascular diseases are involved in distinct signaling
pathways. (C) Downregulated DNA damage checkpoint and repair factors are involved in distinct signaling pathways in different vascular diseases.
Supplementary Table 17, the gene expression changes of DDCFs
were mostly upregulated in human colorectal carcinoma, gastric
cancer, esophageal cell carcinoma, intrahepatic cancer, ovarian
carcinomas, non-small cell lung cancers, clear cell renal cell
carcinomas and Burkitt lymphoma. However, most of the
modulated DDCF genes in adult male germ cell tumors and
breast cancer tend to be attenuated in expression. Mostly, DDRFs
also tend to increase in all the cancer types we analyzed except
in breast cancer. In breast cancer a distinct pattern of DDRFs
modulation could not be observed (3 DDRFs upregulated while
3 downregulated) (Supplementary Table 18).
Taken together, the results suggest that first, various human
cancers significantly induce most of the DDCFs(44 out of
total 58 changes, 75.9%) and DDRFs (32 out of total 45
changes, 71.1%); second, human ovary carcinomas show the
highest induction of DDCFs and DDRFs where human male
germ cell tumors induce depletion of DDCFs, suggesting that
although these are all cancers in the reproductive system,
the gender difference may cause differences in modulating
the expression of DDCFs; third, unlike other cancer types we
analyzed, breast cancer tends to downregulate the expression
of DDCFs, suggesting that breast cancer is different from most
other cancers in modulating DNA damage checkpoint and
repair responses; and fourth, to our surprise, prostate cancer
and pancreatic cancer do not induce any expression changes of
DDCFs and DDRFs, suggesting that DNA damage and repair
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FIGURE 6 | Venn Diagram shows that significantly changed DNA damage checkpoint and repair factor among metabolic diseases and in cells treated with high
glucose and oxidized LDL treatment are mostly disease-specific. (A) Almost equal number of DNA damage response factors are induced and attenuated in metabolic
diseases. Therefore, a distinct pattern of gene modulation cannot be discerned. (B) Venn diagram of the upregulated DNA damage response factors in different
metabolic diseases. (C) Venn diagram of the downregulated DNA damage response factors in different metabolic diseases.
may not contribute significantly to the pathogenesis of those two
cancers.
In addition, we conducted a Venn analysis on
significantly upregulated and downregulated DNA damage
response factors in cancers. Our analysis revealed that
most of these factors are involved in distinct signaling
pathways. However, downregulated and upregulated
factors shared BRCA1 pathway in damage response
and DNA damage induced 14-3-3δ signaling pathways
(Figure 7).
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FIGURE 7 | Modulated DNA response factors in cancer are involved in distinct cellular signaling networks. (A) Upregulated DNA damage response factors (20/68)
and downregulated DNA damage response factors (4/68) modulate different signaling mechanism in human cancers. (B) Venn diagram shows that two signaling
mechanisms are shared between upregulated and downregulated DNA damage response factors in human cancer.
Frontiers in Physiology | www.frontiersin.org 10 May 2018 | Volume 9 | Article 516
Zeng et al. High Genomic Risk and Inflammations
Some of the Inflammatory Disorders That
We Included in Our Study Modulate the
Expression Changes of DDCFs and DDRFs
in Levels Comparable to That of in
Cancers—A New Categorization of High
Genomic Risk Inflammations
It has been reported that the incidence rates of patients with
myocardial infarction (MI) to develop a malignancy within
a few years of post-MI are much high than for individuals
without a history of MI, implying that acute coronary syndrome
or MI may promote malignancies (van Kruijsdijk et al., 2013;
Alameddine et al., 2017; Hasin et al., 2017). We hypothesize
that the inflammations and cancers mediated modulation of the
expression of DDCFs and DDRFs can be used as an index to
determine genomic risks and; this index can be used to classify
inflammation and cancers into several distinct groups.
To test this hypothesis, in Table 1 we classified the 27
inflammatory disorders and 12 cancers into three groups based
on their levels of modulation on the expression of DDCFs
and DDRFs: (1) high genomic risk group with the modulation
of >10% DDCF and DDRF genes), (2) medium genomic risk
group (with the modulation of 10–5% DDCF and DDRF genes)
and (3) low genomic risk group (with the modulation of >5%
DDCF and DDRF genes). We found that: (1) high genomic
risk group included 5 out of 27 inflammatory disorders (18.8%)
and 9 out of 12 cancers (75%); (2) medium genomic risk
group included 7 out of 27 inflammatory pathologies (25.9%)
and 1 out of 12 cancers (8.3%); and (3) low genomic risk
group included 15 out of 27 inflammatory disorders (55.6%)
and 2 out of 12 cancers (16.7%). The high genomic risk group
contained acute coronary syndrome/coronary artery disease,
type 2 diabetes and hyperglycemia, and Hutchinson-Gilford
progeria syndrome. The medium genomic risk group included
Crohn’s colitis, ulcerative colitis, atrophic gastritis, proliferative
diabetic retinopathy, old sepsis-induced multiple organ failure,
rheumatoid arthritis, osteoarthritis. Our data have demonstrated
for the first time that some inflammatory disorders (12 out of
27 inflammations) modulate the expression changes of DDCFs
and DDRFs in the levels equivalent to that of cancers in the high
genomic risk group and medium genomic risk group.
The Expression of Oxygen-Sensing Genes
PHD2, HIF1B, and HIF1A, VEGF Pathway
Genes PGF and VEGFB, and Stem Cell
Master Gene SOX2, and KIT Have a
Positive Correlation With DNA Damage
Response Factors Gene Expression
To determine the relevant mechanisms underlying the regulation
of DDCFs and DDRFs expression in human tissues, we examined
a hypothesis that tissue physiological functional status such as
hypoxia, angiogenesis and tissue regeneration pathways may
regulate the expression of DDCFs and DDRFs in human tissues.
Our data revealed that DDCFs and DDRFs share some key
pathways (data not shown); therefore, each mechanism may
modulate a few genes in specific experimental settings. In order
to determine the shared pathways and mechanisms underlying
DDCFs and DDRFs expression, we grouped them together
as DNA damage response factors. To test this hypothesis, we
performed correlation analysis for the expression of DDCFs and
DDRFs with 4 oxygen sensor genes, 8 vascular endothelial growth
factor (VEGF) pathway genes, 6 stem cell regulator genes and
sex determining region Y-box 2 (Sox2) (Fu et al., 2017). As
shown in Figure 8, among 17 genes examined, the correlation
of seven genes achieved statistical significance (p < 0.05). The
highly expressed DNA damage response potentials were highly
correlated with oxygen-sensing genes PHD2, HIF1B, PGF, and
stem cell master regulator gene SOX2 (high correlation r2 > 0.7).
Low level correlationwas observed betweenHIF1A, VEGFB, KIT,
and highly expressedDNAdamage response potentials (r2 ≤ 0.7).
These results suggested that the expression of oxygen-sensing
genes, PHD2, HIF1B and HIF1A, VEGF pathway genes PGF and
VEGFB, and stem cell master gene SOX2, and KIT have a positive
correlation with DNA damage response gene expression; and
these genes may be either upstream regulators or downstream
targets of DNA damage response gene signaling pathways.
The Expression of 7 and 22% of DNA
Damage Response Factors Are Under
Regulation by Either Hypomethylation or
Hypermethylation Respectively, Whereas
the Expression of the Rest of the 70% of
DNA Damage Response Factors Are Not
Under Regulation by Methylation
Methylation and acetylation of DNA and histone proteins are the
chemical basis for epigenetics. Methylation and acetylation are
sensitive to cellular metabolic status. Modification rates depend
on the availability of one-carbon and two-carbon substrates
(S-adenosylmethionine, acetyl-CoA). In addition, they are
sensitive to demodification enzyme cofactors [α-ketoglutarate,
NAD (+)] and structural analog metabolites that function as
epigenetic enzyme inhibitors (e.g., S-adenosylhomocysteine, 2-
hydroxyglutarate). The combined impact of nutrient abundance
and metabolic enzyme expression impacts epigenetics in
mammals sufficiently to drive important biological outcomes
(Su et al., 2016). The free radicals produced by mitochondrial
metabolism cause DNA damage, suggesting that metabolism-
controlled DNA damage and epigenetic regulation are connected
(Guillaumet-Adkins et al., 2017).
We hypothesized that the expression of certain DDCFs and
DDRFs are under epigenetic regulation such as methylation as
we reported for enzyme expression of homocysteine-methionine
metabolism pathways (Jamaluddin et al., 2007; Chen et al.,
2010). Thus, we analyzed the correlation between mouse co-
signaling receptor expression and mouse tissue methylation
indices determined by the ratios between S-adenosyl methionine
(SAM—the universal methyl donor)/S-adenosyl homocysteine
(SAH—a methyltransferase inhibitor) in mouse tissues (Chen
et al., 2010). As shown in Figure 9, we found that relative
expression levels of five DNA damage response factors in mouse
tissues including Rad1 (r2 = 0.8670, P = 0.0076), Topbp1
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TABLE 1 | Inflammatory diseases and cancers can be classified in to diseases with high, medium, and low genomic risks.
Disease Type Number
(Up and
down-
regulated
Gene)
(Up+Down)% * PMID
Coronary artery disease 18 26% 28344133
Acute coronary syndromes 7 10%
Hutchinson-Gilford progeria
syndrome
Inflammation 13 19%


High genomic
risk group
High glucose (25mM) (5/27, 18.8%) 9 13% 20947488
Type 2 diabetes 7 10%
Ovarian carcinomas 16 24%
Esophageal squamous cell carcinoma 12 18%
Breast cancer 12 18%
Non-small cell lung cancers 12 18%
Burkitt lymphoma Cancer 12 18%
Adult male germ cell tumors (9/12, 75.0%) 10 15%
Clear cell renal cell carcinomas 9 13%
Colorectal carcinoma 7 10%
Gastric cancer 7 10%
Crohn’s colitis 6 9% 28991855
Ulcerative colitis 4 6% 27152873
Atrophic gastritis 4 6% 26958813
Proliferative diabetic retinopathy Inflammation
(7/27, 25.9%)
6 9%
Old sepsis induced multiple organ
failure
6 9%
Rheumatoid arthritis 4 6% 18433475
Osteoarthritis 4 6%
Intrahepatic cancer Cancer (1/12,
8.3%)
6 9%


Medium
genomic
risk group
Aortic occlusive disease 3 4%


Low genomic
risk group
Atheroscleros 3 4%
Oxidized LDL 3 4%
Crohn’s ileitis 3 4%
HP-Infection with
corpus-predominant atrophic gastritis
2 3%
Alzheimer’s disease 3 4%
Old (macular retina) Inflammation 2 3%
Homozygous familial
hypercholesterolemia
(15/27,
55.6%)
2 3%
Psoriasis 2 3%
Asthma patient 1 1%
Systemic lupus erythematosus 0 0%
Diabetic Kidney Disease 0 0%
Type 1 diabetes 0 0%
Metabolic syndrome 0 0%
Homocysteine (100 µmol/L) 0 0%
Pancreatic tumors Cancer 0 0%
Prostate cancer (2/12, 16.7%) 0 0%
This classification is based on the modulation of DDCFs and DDRFs in the diseases condition.
*(Up + Down)% = number of Up and Down-regulated gene/68 in disease.
High genomic risk group: (Up + Down) % ≥10%.
Medium genomic risk group: 5% < (Up + Down) % <10%.
Low genomic risk group: (Up + Down)% ≤ 5%.
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FIGURE 8 | Oxygen sensors, VEGF pathway regulators and stem cell master regulators regulate DNA damage response gene expression in human tissues. (Tissues:
adipose tissue, blood, bone marrow, brain, embryonic tissue, heart, kidney, liver, lung, lymph node, muscle, pancreas, skin, spleen, thymus, vascular). (A) Correlation
between mRNA relative expression levels and specific genes that act as Oxygen Sensor, VEGF pathway genes and stem cell master regulators. (B) Eleven genes with
p < 0.05 were categorized into two tiers based on r2value. PHD2, Prolyl hydroxylase domain-containing protein 2; HIF1B, Hypoxia-inducible factor-1 beta; HIF1/2A,
Hypoxia-inducible factor 1/2-alpha; VEGFA/B/C, Vascular Endothelial Growth Factor A/B/C; FIGF, C-fos-induced growth factor; FLT1/4, Fms related tyrosine kinase
¼; KDR, Kinase insert domain receptor; MYC, MYC proto-oncogene; KIT, KIT proto-oncogene receptor tyrosine kinase; KLF4, Kruppel like factor 4; POU5F1, POU
class 5 homeobox 1; SOX2, SRY-box 2.
(r2 = 0.6870, p= 0.0414), Mgmt (r2 = 0.8194, P= 0.0131), Xrcc3
(r2 = 0.6900, p = 0.0406), Xrcc4 (r2 = 0.6945, p = 0.0394) are
correlated with tissue SAH levels (hypo-methylation index). In
addition, we found that relative expression levels of one DNA
damage response factor Ercc5 in mouse tissues (r2 = 0.8174,
p = 0.0134) are correlated with tissue SAM levels (hyper-
methylation index) (Figure 9). Moreover, as shown in Figure 10,
we found that relative expression levels of 14 DNA damage
response factors in mouse tissues including Atm, Atr, Mre11a,
Chek2, Smug1, Mpg, Ercc8, Ercc2, Lig1, Rad51, Lig3, Rad17,
Brca1, and Pnkp are correlated with tissue SAM/SAH ratios
(hyper-methylation index). These results showed that based on
the methylation regulation modes, 68 DNA damage response
factors can be classified into three groups: (1) hypomethylation-
regulated DNA damage response factors (5 out of 68, 7.4%);
(2) hypermethylation-regulated DNA damage response factors
(15 out of 68, 22.1%); and (3) non-methylation-regulated DNA
damage response factors (48 out of 68, 70.6%).
Finally, we examined a hypothesis that top 10 signaling
pathways in regulating these three groups of genes are
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FIGURE 9 | Tissue methylation status regulated by SAM levels modulate DNA damage response. (A) Correlation between DNA damage response factors and
hypomethylation status. (B) Correlation between DNA damage response factors and hypermethylation status.
different. To test this hypothesis, we performed the Ingenuity
pathway analysis for the top 10 pathways for each group
of genes followed by the Venn diagram analysis. The results
shown in Supplementary Figures 2, 3 indicate that first,
hypermethylation may regulate DNA damage response factor
expression via two specific pathways including cell cycle: G2/M
DNA damage checkpoint regulation and GADD45 signaling;
second, hypomethylation may regulate DNA damage response
factor expression via four specific pathways includingmethionine
degradation I (to homocysteine), cysteine biosynthesis III
(mammal), superpathway of methionine degradation, and p53
signaling; and third, the majority DNA damage response factors
whose expression are not under methylation regulation also
have three specific pathways including nucleotide excision
repair pathway, mismatch repair in eukaryotes, and type III
histone/protein deacetylase sirtuin signaling pathway as we
reported (Yin et al., 2015).
Proinflammatory Cytokines May Induce
DNA Damage Responses by Significantly
Increasing the Expression of DNA Damage
Checkpoint Factors and Decreasing the
Expression of DNA Repair Factors
We then examined a hypothesis that various inflammatory
cytokine pathways may modulate the expression of DDCFs and
DDRFs. Therefore, we examined DDCFs and DDRFs expression
in various cells stimulated by prototypic pro-inflammatory
cytokines including tumor necrosis factor-α (TNF-α) (Yang
et al., 2008), interleukin-17A (IL-17A) (Mai et al., 2016),
interferon-γ (IFN-γ), IL-1β (Yin et al., 2013), IL-6, IL-33,
alarmin S100A8 (myeloid-related protein 8, MRP8 Rammes
et al., 1997; Averill et al., 2012; Holzinger and Roth, 2016),
as well as endotoxin lipopolysaccharide (LPS) (Sha et al.,
2015).
Frontiers in Physiology | www.frontiersin.org 14 May 2018 | Volume 9 | Article 516
Zeng et al. High Genomic Risk and Inflammations
FIGURE 10 | Tissue SAM/SAH ratio may regulate DNA damage response factors expression in mouse tissues.
As shown in Supplementary Tables 19, 20, pro-inflammatory
cytokines can regulate the expression of DDCFs and DDRFs.
Interestingly, pro-inflammatory stimuli such as LPS, MRP8,
TNF-α and IL-1β exert a profound effect on interleukin-1α in
human blood cells. Compared to DDCFs, DDRFs tend to be
downregulated more with pro-inflammatory stimuli, suggesting
pro-inflammatory cytokines may induce DNA damage responses
by significantly decreasing the expression of DDRFs. We also
conducted an IPA (Ingenuity pathway analysis) on significantly
upregulated and downregulated DNA damage response factors
due to response to cytokine treatment. While many of the
signaling pathways are specific for cytokine induced and
attenuated DNA response factors, three pathways were common
for both groups. These pathways are DNA DSB (double strand
break) repair by homologous recombination, DNA DSB repair
by non-homologous end joining, and BER pathway (Figure 11).
Frontiers in Physiology | www.frontiersin.org 15 May 2018 | Volume 9 | Article 516
Zeng et al. High Genomic Risk and Inflammations
FIGURE 11 | Pro-inflammatory cytokines regulate the expression of DNA damage response factors. (A) Downregulated DNA damage response factors (25/68) and
upregulated DNA damage response factors (8/68) by cytokine treatment are involved in different signaling mechanisms. (B) Three pathways are shared between
upregulated and downregulated DNA damage response factors after treatment with pro-inflammatory cytokines.
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Oxidative Stress Sensing and Protective
Genes do Not Significantly Modulate the
Expression of DDCFs and DDRFs
Inflammatory and epithelial cells release reactive oxygen (ROS)
and nitrogen species (RNS), which are capable of causing
DNA damage (Kawanishi et al., 2017). We hypothesized that
oxidative stress induces DNA damage response by modulating
the expression of DDCFs and DDRFs.
Transcription factor Nrf2 (NF-E2-related factor 2) is a
master regulator of cellular responses against environmental
stresses. Nrf2 induces the expression of detoxification and
antioxidant enzymes and suppresses the induction of pro-
inflammatory cytokine genes (Suzuki and Yamamoto,
2017). Therefore, we analyzed the expression changes
of DDCFs and DDRFs in NRF2 deficient cell/tissue in
comparison to that of wild-type controls. The microarray
datasets we used for this analysis were conducted on mouse
esophageal epithelium and liver. Our analysis revealed
that the absence of Nrf2 did not induce any significant
changes in the expression of DDCF except interleukin-
1alpha (IL1α) (Supplementary Table 21). Further, Nrf2
deficiency downregulated the expression of a few DDRF
genes (Supplementary Table 22).
Keap1 (Kelch-like ECH-associated protein 1) is an adaptor
subunit of Cullin 3-based E3 ubiquitin ligase. Keap1 regulates the
activity of Nrf2 and acts as a sensor for oxidative and electrophilic
stresses (Suzuki and Yamamoto, 2017). Therefore, we studied the
expression changes of DDCFs and DDRFs in Keap1 deficient
cells/tissues microarray in comparison to that of wild-type
controls.We could not detect significant gene expression changes
for any of the DDCFs we included in this study. The expression of
RAD23B and ERCC8 (DDRFs) were significantly downregulated
in the absence of Keap1 (Supplementary Tables 21, 22).
In addition, we studied the gene expression changes of DDCFs
and DDRFs in Forkhead box protein O1 (FoxO1) deficient
hematopoeitc stem cells. FoxOs are transcription factors that
orchestrate programs of gene expression known to control a
variety of processes in response to cellular stress. The genes
regulated by this family of transcription factors are involved
in the regulation of cellular energy production, oxidative
stress resistance and cell viability and proliferation (Link and
Fernandez-Marcos, 2017). FoxO1 deletion induced the gene
expression of three DDCFs. Most significantly, FoxO1 deletion
induced around 12 fold changes of IL1A gene expression in
hematopoietic stem cells inducedDDCF IL1A.However, deletion
of FoxO1 did not trigger gene expression changes of DDRFs in
hematopoietic stem cells (Supplementary Tables 21, 22).
There is likely a dichotomy whereas superoxide dismutase
2 (SOD2) can be considered a protective antioxidant, as well
as a pro-oxidant during cancer progression depending on the
level of accumulation and detoxification of H2O2 (Ekoue et al.,
2017). Therefore, we studied the expression changes of DDCFs
and DDRFs in SOD2 deficient cells/tissues in comparison to
that of wild-type controls. SOD2 deficiency did not affect the
expression of DNA damage response factors except MSH6
(DDRF) (Supplementary Tables 21, 22).
Continuously elevated ROS levels will result in oxidative
stress and development of disease, but likewise, insufficient
ROS production will be detrimental to health. Reduced or
even complete loss of ROS generation originates mainly
from inactivating variants in genes encoding for nicotinamide
adenine dinucleotide phosphate (NADPH) oxidase complexes.
In particular, Nox2 oxidase function deficiency in phagocytes
due to genetic variants (CYBB, CYBA, NCF1, NCF2, and
NCF4) has been recognized as a direct cause of chronic
granulomatous disease (CGD), an inherited immune disorder.
Thus, we studied the expression changes of DDCFs and DDRFs
in neutrophil cytosolic factor 1 (also known as p47-phox, NCF1)
deficient blood and found that NCF1 absence does not alter the
expression of DNA damage response factors relative to controls
(Supplementary Tables 21, 22).
Transient increase of stressors during acute bouts of exercise
or exercise training stimulate enhancement of cellular stress
protection against future insults of oxidative, metabolic and
mechanical stressors that could induce injury or disease,
which has been termed as exercise preconditioning (EPC).
EPC stimulates transcription factors such as Nrf-1 and heat
shock factor-1 and up-regulate the gene expression of cytosolic
(e.g., glutathione peroxidase and heat shock proteins) and
mitochondrial adaptive or stress proteins [e.g., manganese
superoxide dismutase, mitochondrial KATP channels and
peroxisome proliferator activated receptor γ coactivator-1 (PGC-
1)]. Thus, we studied the expression changes of DDCFs and
DDRFs in PGC-1 deficient muscles in comparison to that of
wild-type controls. We could not detect gene expression changes
of any of the DNA damage response factors compared to the
controls in this dataset (Supplementary Tables 21, 22).
When summarized the data shown in Supplementary Tables
21, 22, it is obvious that the oxidative stress associated gene
deficiencies we studied affect changes in the expression of few
DDCFs and DDRFs.
Intracellular Organelle DAMPs Significantly
Modulate the Expression of DDCFs and
DDRFs
After determining the expression changes of DDCFs and DDRFs
under physiological and pathological conditions, we focused on
identifying the potential mechanisms that may modulate the
expression of these factors under various cellular stresses. Danger
associated molecular patterns (DAMP) regulate inflammation
and is known to give rise to many sterile inflammatory
disorders. Several previous reports including ours demonstrated
that DAMP-sensor caspase-1 can cleave nuclear protein-type II
histone deacetylase sirtuin-1 and promotes endothelial activation
(Yin et al., 2015), suggesting caspase-1 can sense nuclear
DAMPs. Additionally, presence of nuclear inflammasomes
and extracellular exosome-based inflammasomes was reported,
suggesting that DAMPs located in different organelles can
trigger inflammation (Wang L. et al., 2016). Further, our
newly proposed conditional DAMP (Wang X. et al., 2016)
lysophosphatidylcholine (lysoPC) induces mitochondrial ATP
generation-uncoupled mitochondrial reactive oxygen species
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increase and endothelial activation gene upregulation (Li et al.,
2016), suggesting that mitochondrial DAMPs can activate
nuclear programs for gene transcription.
Signaling between nucleus and other intracellular
organelles can be of both directions. For an example,
hyperhomocysteinemia induced epigenetic program stress
facilitate hypomethylation that leads to mitochondrial
dysfunction, which in turn “signals back” to nucleus and
causes cell death (Xi et al., 2016). Therefore, we examined a novel
hypothesis that intracellular organelle stress-induced DAMPs
modulate the expression of DDCFs and DDRFs. Here we studied
six intracellular organelle stresses: endoplasmic reticulum (ER),
Golgi complex, lysosomes, endosomes, mitochondria and by
activation of autophagy.
The ER stress response is triggered by a variety of conditions
that disturb folding of proteins in the ER. The unfolded protein
response (UPR) aims to clear unfolded proteins and restore ER
homeostasis. In case where ER stress cannot be reversed, cellular
functions deteriorate, leading to cell death and contribute to
many diseases (Sano and Reed, 2013; Frakes and Dillin, 2017).
Increased protein load not only causes an ER stress response but
also causes Golgi stress response akin to UPR. Recent work has
implicated eight basic Leucine Zipper (bZip) transcription factors
in the regulation of protein components of the early secretory
pathway are necessary to alleviate this stress. These include
components of the three canonical branches of the UPR–ATF4,
XBP1, and ATF6, as well as the five members of the Creb3 family
of transcription factors (Fox and Andrew, 2015). Furthermore,
Perk activation is required to activate UPR and subsequent
ER stress. Hence, we studied the expression of DNA damage
response factors in Perk-/- and Atf4-/- embryonic fibroblasts
and Xbp-/- telenchephalon. Of note, in this study Atf4 was
considered as a Golgi stress marker. As shown in Table 2, Perk
deficiency did not affect the gene expression of DDCFs however,
induced the expression of XPC, BRCA2, MLH2, andMLH3. Lig3
expression was attenuated in Perk deficient mouse fibroblasts. In
contrast, Xbp deficiency did not affect the expression of DDRFs
but induced the expression of BRCA1 in mouse telenchephalon.
The Golgi stress marker Atf4 absence suppressed the expression
of few DDCFs and induced the expression of two DDRFs.
Niemann-Pick C1 (NPC) disease, an autosomal recessive lipid
trafficking disorder caused by loss-of-function mutations in the
NPC1 gene, is characterized by progressive neurodegeneration.
Lysosomes are stressed in Npc1-deficient cells, where lysosomal
cathepsins are mis-localized within the cytosol. Thus, damage to
lysosomal membranes by reactive oxygen species (ROS) leads to
the leakage of lysosomal contents that culminates in apoptotic
cell death (Chung et al., 2016). Therefore, we chose Npc1
as an indicator for lysosomal stress. Npc1 deficiency induced
the expression of BRCA1 (a DDCF) and downregulated the
expression of MSH3 (a DDRF) (Tables 2, 3).
Rab5 is the most extensively analyzed member of the Rab
family (a branch of the Ras superfamily of small GTPases). Rab5
is involved in the early endocytic pathway. It regulates the entry
of cargo from the plasmamembrane to the early endosomes (EE),
generation of phosphotidylinositol-3-phosphate (PtdIns(3)P)
lipid which is enriched on EE, homotypic fusion and the motility
of EE on actin and microtubules tracks. In addition, it also
functions in activating signaling pathways from EE (Jovic et al.,
2010). Therefore, Rab5 is a potential marker for endosomal stress.
When analyzed the gene expression changes of DNA damage
response factors in Rab-/- mouse liver, we found that it induces
the expression of two DDCFs including BRCA1. Further, Rab5
deficiency upregulated the expression of 2 DDRFs (Tables 2, 3).
Recent work uncovered a PINK1/parkin-dependent vesicle
transport pathway wherein oxidized or damaged mitochondrial
content are selectively delivered to the late endosome/lysosome
for degradation. Syntaxin-17 is found to be a core mitochondrial
canonical soluble NSF attachment protein receptor (SNARE)
required for the delivery of stress-induced PINK1/parkin-
dependent mitochondrial-derived vesicles (MDVs) to the late
endosome/lysosome. VAMP7 forms a ternary SNARE complex
with syntaxin-17 and SNAP29 to mediate MDV-endolysosome
fusion (McLelland et al., 2016). Therefore, we recognized VAMP7
as another marker for lysosomal stress. Unlike Rab5, VAMP7
deficiency did not affect the expression of DDRFs. However,
VAMP7-/- induced the expression of ATRIP, H2AFX and ATR
(DDCFs) relative to the control (Tables 2, 3).
Mammalian CLPP has an essential role in determining the
rate of mitochondrial protein synthesis by regulating the level
of mito-ribosome assembly (Szczepanowska et al., 2016). Hence,
we identified the CLPP as a mitochondrial stress marker. When
analyzed the expression changes of DNAdamage response factors
in CLPP deficient mouse testis, we observed that it affects the
expression of as many as 11 DDRFs. Further, absence of CLPP
affected the expression of 5 DDCFS, where for of these genes were
upregulated (Tables 2, 3).
In addition, we analyzed the expression changes of DNA
response factors in the absence of Pink1. Pink1 (PTEN-induced
putative kinase (1) and PARK2 (E3 ubiquitin protein ligase
Parkinson’s disease protein 2 also known as parkin) are two
genes associated with familial Parkinson’s disease and have a
crucial role in mitophagy, partly by modulating mitochondrial
fusion and fission (Andreux et al., 2013). Pink1 deletion induced
BRCA1 expression in mouse cerebellum while downregulating
the expression of two DDRFs (Tables 2, 3).
Selective survival could bemediated by suppression of reactive
oxygen species and oxidative stress (mitophagy) or limiting
ER stress-induced apoptosis (reticulophagy). By mitigating such
stress, autophagy prevents DNA damage and caspase activation,
but can also directly crosstalk with DNA damage machinery
(Riffelmacher and Simon, 2017). Atg7 and Atg16L1 are genes
that regulate autophagy in response to stress conditions in cells.
Therefore, we hypothesized that the autophagy can affect the
expression of DDCFs and DDRFs. Atg7 absence in mouse liver
induced the expression of H2AFX (a DDCF), LIG1 (a DDRF),
and RAD52 (a DDRF). Further, deletion of Atg16l1 significantly
downregulated the expression of 2 DDCFs and upregulated the
expression of 2 DDRFs.
Further, we conducted an IPA analysis on the induced
and attenuated DNA damage response factors in response to
intracellular organelle stresses. While some pathways are specific,
we observed that 5 signaling pathways are common for both
groups (Supplementary Figure 4).
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TABLE 2 | The gene expression changes of DNA damage checkpoint factors in response to intracellular organelle stress.
Endoplasmic
reticulum
stress
Endoplasmic
reticulum
stress
Golgi
stress
Lysosome
stress
Lysosome
stress
Endosome
stress
Mitochondrial
stress
Mitochondrial
stress
Autophagy Autophagy
GEO ID GSE49598 GSE11322 GSE75150 GSE39621 GSE56102 GSE67227 GSE40207 GSE60413 GSE67676 GSE13512
Tissue Mouse
embryonic
fibroblast
Mouse
telencephalon
Mouse
embryonic
fibroblast
Mouse
brain
Human
embryonal
carcinoma
NTERA2 D/1
cells
Mouse
liver
Mouse
testis
Mouse
cerebellum
Mouse
liver
Mouse
paneth cells
Comparison Perk-/-
vs. wild-type
mice
Xbp1-/- vs.
wild-type mice
Atf4-/- vs.
wild-type mice
Npc1–/–
vs. Npc1+/–
mice
VAMP7
knockdown
siRNA vs.
control
Rab5-/- vs.
wild-type mice
ClpP-/- vs.
wild-type mice
Pink1-/- vs.
wild-type mice
Atg7
conditional
knock out vs.
wild-type mice
Atg1611
mutant vs.
wild-type mice
RAD9A
RAD1
HUS1
MRE11A 0.46
RAD50
NBN
RPA1
RPA2
RPA3
ATRIP 3.11
RAD17
PARP1 2.03
PARP2
XRCC6
XRCC5
IL1A
BRCA1 5.42 0.43 2.41 2.33 2.11
TOPBP1 2.52
TP53BP1 0.33
MDC1
H2AFX 0.42 6.37 2.6 2.23
ATM
ATR 6.3 2.03 0.46
PRKDC
CHEK1 0.49 2.36 0.44
CHEK2
Up 0 1/26 0 1/26 3/26 2/26 4/26 1/26 1/26 0
Down 0 0 3/26 0 1/26 0 1/26 0 0 2/26
- Genes with significant expression changes (P < 0.05) are shown here. Red text stands for upregulation (FC ≥2), green text stands for downregulation (FC ≤ 0.5).
Perk, protein kinase RNA-like endoplasmic reticulum (ER) kinase; Xbp1, X box-binding protein 1; Atf4, activating transcription factor 4; Npc1, Niemann Pick type C 1; Rab5, Ras-related
protein Rab-5A; ClpP, ClpP caseinolytic peptidase, ATP-dependent, proteolytic subunit; Pink1, PTEN induced putative kinase 1; Atg7, Autophagy related 7; Atg16l1, Autophagy related
16-like 1; VAMP7, vesicle-associated membrane protein 7.
As shown in Tables 2, 3, it can be concluded that
intracellular organelle stresses can affect the expression of
DNA damage response factors. Out of the organelle stresses
we studied, our analysis shows that mitochondrial stress
profoundly affect the gene expression of DDCFs and DDRFs.
Also, we observed that the expression of DDCF BRCA1 is
significantly altered in ER, Golgi, lysosomal, endosomal, and
mitochondrial stresses. Therefore, BRCA1might be an important
mediator in receiving the stress signals from intracellular
organelles.
DISCUSSION
It has been reported that chronic inflammation contributes
approximately to 25% of human cancers (Kawanishi et al., 2017).
Under inflammatory conditions, inflammatory cells release
reactive oxygen species (ROS) and reactive nitrogen species
(RNS), which cause DNA damage. In addition, DNA damage
also induces inflammation and senescence (Kang et al., 2015).
However, regardless of the significant progress made in the field,
a comprehensive analysis of tissue expression profile of DDCFs
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TABLE 3 | The gene expression changes of DNA damage repair factors in response to intracellular organelle stress.
Endoplasmic
reticulum
stress
Endoplasmic
reticulum
stress
Golgi
stress
Lysosome
stress
Lysosome
stress
Endosome
stress
Mitochondrial
stress
Mitochondrial
stress
Autophagy Autophagy
GEO ID GSE49598 GSE11322 GSE75150 GSE39621 GSE56102 GSE67227 GSE40207 GSE60413 GSE67676 GSE13512
Tissue Mouse
embryonic
fibroblast
Mouse
telencephalon
Mouse
embryonic
fibroblast
Mouse
brain
Human
embryonal
carcinoma
NTERA2
D/1 cells
Mouse
liver
Mouse
testis
Mouse
cerebellum
Mouse
liver
Mouse
paneth cells
Comparison Perk-/-
vs. wild-type
mice
Xbp1-/- vs.
wild-type mice
Atf4-/- vs.
wild-type
mice
Npc1-/-
vs.
Npc1+/-
mice
VAMP7
knockdown
siRNA vs.
control
Rab5-/-
vs.
wild-type
mice
ClpP-/- vs.
wild-type mice
Pink1-/- vs.
wild-type mice
Atg7
conditional
knock out
vs.
wild-type
mice
Atg1611
mutant vs.
wild-type
mice
MGMT
ALKBH2
ALKBH3
OGG1 3.53
NEIL1
MUTYH
UNG 2.18
SMUG1
MPG
APEX1
APEX2
POLB
PNKP
XPC 2.00 2.21 2.54
RAD23B 0.43] 0.33
XPA
ERCC2
ERCC3
ERCC1
ERCC5
ERCC4 0.25 0.38
LIG1 0.50 2.36 2.23 3.79
ERCC8 0.43
ERCC6
XRCC2 0.42 2.87
XRCC3
BRCA2 2.17
RAD52
RAD51 3.75 2.83 2.05
LIG4
NHEJ1
XRCC4
XRCC1
LIG3 0.41 0.21
MLH1
MLH3 3.18
MSH2 2.18 3.09
MSH3 2.01 0.38
MSH6
PMS1
PMS2 2.95
HMGB1 3.19
Up 4/42 0 2/42 0 0 2/42 7/42 0 2/42 2/42
Down 2/42 0 1/42 1/42 0 0 4/42 2/42 0 0
-Genes with significant expression changes (P < 0.05) are shown here. Red text stands for upregulation (FC ≥2), green text stands for downregulation (FC ≤ 0.5).
Perk, protein kinase RNA-like endoplasmic reticulum (ER) kinase; Xbp1, X box-binding protein 1; Atf4, activating transcription factor 4; Npc1, Niemann Pick type C 1; Rab5, Ras-related
protein Rab-5A; ClpP, ClpP caseinolytic peptidase, ATP-dependent, proteolytic subunit; Pink1, PTEN induced putative kinase 1; Atg7, Autophagy related 7; Atg16l1, Autophagy related
16-like 1; VAMP7, vesicle-associated membrane protein 7.
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and DDRFs under physiological conditions in human and mouse
tissues was not conducted before. Further, how the expression of
DDCFs and DDRFs are modulated in human pathologies such
as cancers and sterile inflammatory disorders and the potential
signalingmechanisms that are involved in themodulation are not
fully known.
To address these significant issues, we took a panoramic,
nonbiased, experimental data mining approach and analyzed
many publicly available databases and microarray datasets. We
have made several important findings: (1) Among 26 DNA
damage checkpoint factors expressed in human 21 tissues, four
factors including PARP1, XRCC6, XRCC5, and PRKDC are
ubiquitously expressed; and others are differentially expressed
in human tissues. (2) Among 42 DNA damage repair factors,
six factors including APEX1, XPC, ERCC3, ERCC5, HMGB1,
and MLH1 are ubiquitously expressed; and other DDRFs are
differentially expressed in human tissues. (3) Human vascular,
autoimmune, digestive, aging diseases have the tendency to
upregulate than downregulate the expression of DDCFs and
DDRFs. Herein, we acknowledge that the datasets that we have
used to study the effect of vascular diseases on DDCFs and
DDRFs expression were mostly conducted on blood cells. Thus,
the expression changes we observed in the blood cells may not be
directly correlated to the diseased tissues. (4) Metabolic diseases
did not show a distinct pattern in gene modulation of DDCFs
and DDRFs, maybe due to tissue specific responses to metabolic
changes. (5) Various human cancers upregulate the expression
of DDCFs and DDRFs with an exception in pancreatic cancers
and prostate cancers, where overall modulation of DNA damage
response factors was not observed. In contrast, downregulation
of DDCFs and DDRFs were observed in male germ cell tumors.
However, the gene expression changes during cancers may be
more complicated thanwhat we report here. It is highly likely that
different gene expression patterns may emerge during different
stages of cancer progression (Zhou et al., 2003; Garnis et al.,
2004). Therefore, more studies are required to discern the
patterns of DNA damage response factor expression changes
during cancer progression. (6) The expression of oxygen-sensing
genes, PHD2, HIF1B, and HIF1A, VEGF pathway genes PGF and
VEGFB, and stem cell master gene SOX2, and KIT have a positive
correlation with DNA damage response factor gene expression,
suggesting that tissue oxygen levels, angiogenesis potential and
stem cell regeneration are associated with DNA damage response
factor gene expression. (7) The expression of 7 and 22% of
DNA damage response factors are under regulation by either
hypomethylation or hypermethylation, respectively, whereas the
expressions of the rest of 70% of DNA damage response factors
are not regulated by the tissue methylation status. This suggests
that the expression of 1/3 of DNA damage response factors
are under regulation by the methylation status (Jamaluddin
et al., 2007). (8) Proinflammatory cytokines may induce DNA
damage responses by significantly increasing the expression of
DDCFs and decreasing the expressions of DDRFs, providing a
direct evidence that proinflammatory cytokine pathways regulate
genomic stability. (9) Oxidative stress sensing and protective
genes do not significantly modulate the expression of DDCFs
and DDRFs. (10) Intracellular organelle stresses significantly
modulate the expression of DDCFs and DDRFs. The DDCF
BRCA1 was modulated in ER, Golgi, lysosomal, endosomal,
and mitochondrial stress. Further, mitochondrial stress has a
profound effect on gene modulation of DNA damage response
factors. This suggest that intracellular organelle stresses can relay
the stress signals to the nucleus that may determine the genomic
stability of the cells. Therefore, DNA damage response factors
serve as converged downstream sensors for various intracellular
organelle stresses and global cellular homeostasis. Thus, we
propose a new classification of high genomic risk inflammatory
disorders that profoundly affect the genome integrity leading to
inflammatory cell death, gene mutations and carcinogenesis.
For the analysis, we used an experimental database mining
approach that was pioneered and developed in our laboratory
throughout the years (Yang et al., 2006; Yin et al., 2009;
Li et al., 2012). By analyzing high precision sequencing
data from tissue cDNA libraries, we were able to study the
expression profiles of DDCFs and DDRFs in various tissues.
Although these data are collected from cDNA cloning and DNA
sequencing experiments rather than theoretical data derived
from computer modeling, the data we reported are more
applicable to biological systems. Since the gene expression
sequencing tag (EST) data deposited in the NIH-NCBI-UniGene
database have been established based on DNA sequencing data,
the data obtained by EST database mining are more precise in
providing the tissue expression profiles of genes than traditional
hybridization- and primer annealing-based approaches like
Northern blots and RT-PCRs (Yin et al., 2009). Of note, since
the UniGene database does not have many non-tumor cell line-
related gene expression data in various gene deficiencies and
stimulation conditions, we analyzed micro-array based gene
expression data deposited in NIH-GEO Datasets to determine
the expression changes of DDCFs and DDRFs under pathological
conditions.
Previous reports showed that DDCFs and DDRFs have
expression differences in tissue-specific stem cells (Blanpain et al.,
2011; Mandal et al., 2011). However, our findings presented
in this paper were not reported previously. Therefore, our
results significantly improve our understanding on the human
and mouse tissues expression profiles of DDCFs and DDRFs.
More importantly, we have systemically analyzed the expression
changes and underlying signaling pathways of DDCFs and
DDRFs in various human inflammations and cancers, which
provide novel insights over previously overlooked, long-term
genomic stability effects exerted by these disorders.
Based on our findings, we propose a new working model
on inflammatory pathologies, cancers, and genomic stability
(Figure 12). Our new model integrates the following new
findings: First, in Figure 12A, the effect of inflammation
and cancers on the expression of DDCFs and DDRFs can
be used as an index for determining the genomic risk. By
using this index, we can classify inflammatory disorders and
cancers into three groups categorized as high-, medium-, and
low- genomic risks. Moreover, danger associated molecular
patterns (DAMPs)/pathogen associated molecular patterns
(PAMPs) bind to DAMP-receptors and PAMP-receptors and
subsequently to inflammation cytokine receptors and generate
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FIGURE 12 | A new working model on cellular sensor cross-talking network. (A) Our new model integrates the following new findings: First, sterile inflammatory
disorders and cancers can be classified into high, medium and low genomic risk groups based on the level of modulation of DNA damage response factors.
Diseases-related danger associated molecular patterns (DAMPs)/pathogen associated molecular patterns (PAMPs) bind to DAMP- and PAMP-receptors respectively,
leading to subsequent activation of downstream cytokine receptors to generate intracellular organelle stresses. One possible mechanism that intracellular organelle
stresses may modulate DNA damage response factor expression is by regulating the methylation status of the cells and via canonical and non-canonical
inflammasomes pathways. (B) The interplay between DDCFs and DDRFs under physiological and pathological conditions lead to either the maintenance or loss of
balance between DNA damage and DNA repair mechanisms. The balance between DNA damage and DNA repair lead to maintenance of genomic stability and cell
health. In contrast, increased DNA damage but decreased DNA repair would result in genomic instability and subsequent inflammatory cell death, gene mutations and
carcinogenesis.
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intracellular organelle stresses. Also, our data revealed that
intracellular organelle stresses can induce DDCFs and DDRFs.
This indicates that by direct and indirect mechanisms that are
yet to be determined, organelle insults relay stress signals to
the nucleus, which may determine the cell fate by modulating
the genomic stability via modulation of DDCFs and DDRFs.
This also suggest that DDCFs and DDRFs can act as nuclear
sensors for intracellular organelle stresses. Though extensive
experimental validation is required, our data suggest that
epigenetic pathways such as hypo-/hyper-methylation pathways,
canonical/non-canonical inflammasome pathways and cytokine
signaling pathways are potential molecular mechanisms that
may be utilized by organelles to convey the stress signals to the
nucleus.
Figure 12B shows that the interplay between DDCFs and
DDRFs under physiological and pathological conditions lead
to either balance between DNA damage and DNA repair;
or loss of the balance by increased DNA damage in the
presence of decreased DNA repair. Maintaining the balance
between DNA damage and DNA repair is essential to maintain
genomic stability and cellular health. In contrast, increased
DNA damage but decreased DNA repair will result in genomic
instability and subsequently inflammatory cell death, gene
mutations and carcinogenesis. This new working model has
provided novel insights on DNA damage responses and DNA
damage repair under various human diseases and cancers as
well as novel therapeutic targets for improvement of genomic
stability and cell health. Also our work suggest possible
signaling mechanisms that maybe involved in transmitting
organelle stress signals to the nucleus which ultimately
decide the cell death by modulating DDCFs and DDRFs
expression.
As mentioned above, for the first time we propose a novel
concept that DDCFs and DDRFs can act as nuclear sensors
(Wang L. et al., 2016) for organelle stresses, which is a
part of cellular sensor cross-talking network including classical
DAMP receptors such as Toll-like receptors (Yang et al., 2008),
caspase-1/Nod-like receptors and inflammasomes (Yin et al.,
2013), conditional DAMPs receptors and our newly proposed
homeostasis-associated molecular pattern receptors (Wang X.
et al., 2016; Li et al., 2017a; Wang et al., 2017; Sun et al., 2018),
and mitochondrial ROS (Li et al., 2013, 2016, 2017b; Cheng et al.,
2017).
CONCLUSIONS
In summary, our study shows that most of the DDCFs and
DDRFs are differentially modulated in tissues. Further, various
sterile inflammatory disorders and cancers alter the gene
expression of DDCFs and DDRFs. Our study also shows that
DAMP mediated organelle stresses may converge to the nucleus,
where the cell fate will be determined by maintaining of genomic
stability. DDCFs and DDRFs may act as nuclear danger sensors
for detecting intracellular organelle stresses. Therefore, the
DDCFs and DDRFs that are modulated in human inflammation
and cancers may serve as novel biomarkers for diagnosis and
prognosis, and novel therapeutic targets for treatment of these
diseases.
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